Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
about
Immunotherapy for solid tumors--a review for surgeons.Prognostic factors in hodgkin lymphomaInterferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder.Hodgkin's lymphoma therapy: past, present, and future.Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-AnalysisCirculating interleukin-10 levels and human papilloma virus and Epstein-Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects.Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.Prognostic Biomarkers for Hodgkin Lymphoma.Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma.Interleukin 10 (IL10) proximal promoter polymorphisms beyond clinical response in classical Hodgkin lymphoma: Exploring the basis for the genetic control of the tumor microenvironment.Elevated Serum Levels of IL-10 are Associated with Inferior Progression-Free Survival in Patients with Hodgkin's Disease Treated with Radiotherapy
P2860
Q33709232-A5D0FADA-E0AF-4AD1-A9A0-F8A3BC079191Q33920147-36D20367-8692-417C-9404-28BEB95984F3Q34275888-905C065F-F3FC-4D03-AA73-E7A85D768CD4Q34296914-088DECF1-21C2-4E42-BC0D-1FAF6E1A02E0Q34501005-560B3A10-5978-4FBB-8821-AD71B8D7DD8CQ36127128-F7D40D81-4D8F-4D04-9B14-F61073BC07FAQ36677481-D5F2B256-F6AA-4B66-95CE-4645A686154EQ37271829-D8D5EDE3-7C83-4BC0-9DC9-C17D576706AFQ38375380-472AB97C-21AA-4D5A-92D0-9D768A68E39AQ38588503-AACC5514-639A-4010-8449-E4C66D5F724AQ51040404-4CF95C45-0901-4470-8839-0C232ABDDCBAQ52803465-A16EEBFA-0B13-4189-9A4D-B5C3C466BAA4Q58924303-E9A70A59-D590-4FE6-91FE-E52138EFA743
P2860
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Elevated pretreatment serum le ...... n cancer institute experience.
@en
Elevated pretreatment serum le ...... n cancer institute experience.
@nl
type
label
Elevated pretreatment serum le ...... n cancer institute experience.
@en
Elevated pretreatment serum le ...... n cancer institute experience.
@nl
prefLabel
Elevated pretreatment serum le ...... n cancer institute experience.
@en
Elevated pretreatment serum le ...... n cancer institute experience.
@nl
P2093
P356
P1433
P1476
Elevated pretreatment serum le ...... n cancer institute experience.
@en
P2093
P2888
P356
10.1007/BF02826218
P577
2000-02-01T00:00:00Z
P6179
1003252454